STOCK TITAN

Proposed 50,000-share sale by CLYM broker (CLYM)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filing reporting a proposed sale of 50,000 common shares by a broker-dealer on 02/25/2026. The filing lists prior 10b5-1 sales by Stephen Thomas of 10,000 shares on 02/13/2026 for $58,141 and 90,000 shares on 02/12/2026 for $470,984. The securities are listed as common shares on NASDAQ.

Positive

  • None.

Negative

  • None.

Insights

Routine resale disclosure showing planned broker-mediated sale and recent 10b5-1 transactions.

The filing lists a proposed sale of 50,000 common shares with a 02/25/2026 date and records two recent 10b5-1 sales by Stephen Thomas: 10,000 shares on 02/13/2026 for $58,141 and 90,000 shares on 02/12/2026 for $470,984.

These items are disclosure of transactions; their impact depends on subsequent sale execution and volume. Subsequent filings will show actual sale amounts and completion status.

Filing reflects a broker-mediated resale notice rather than an issuance of new shares.

The entry shows the broker-dealer and an intended offer of 50,000 common shares on 02/25/2026, and cites recent executed 10b5-1 trades with aggregate proceeds reported as $529,125 across two dates.

Trade timing, execution method, and whether the listed shares are offered immediately or over time are not specified here; subsequent confirmations would state execution details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CLYM Form 144 report say?

The filing reports a proposed sale of 50,000 common shares on 02/25/2026. It also lists recent 10b5-1 sales of 10,000 and 90,000 shares on 02/13/2026 and 02/12/2026.

Who executed recent 10b5-1 sales disclosed in the filing?

The filing identifies Stephen Thomas as the reporting person for 10b5-1 sales. It records sales of 10,000 shares on 02/13/2026 and 90,000 shares on 02/12/2026 with reported proceeds.

How much cash was reported from the recent 10b5-1 sales?

The excerpts report proceeds of $58,141 for the 10,000-share sale on 02/13/2026 and $470,984 for the 90,000-share sale on 02/12/2026, as shown in the filing.

Are the 50,000 shares in the Form 144 newly issued?

The filing lists 50,000 common shares to be sold; it identifies the entry as a resale notice with NASDAQ listing. The record does not state that these are newly issued shares.
Climb Bio

NASDAQ:CLYM

CLYM Rankings

CLYM Latest News

CLYM Latest SEC Filings

CLYM Stock Data

483.43M
67.63M
Biotechnology
Pharmaceutical Preparations
Link
United States
WELLESLEY HILLS